Outcomes in patients (pts) aged ≥ 65 years in the phase 3 ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC) Meeting Abstract
| Authors: | Kalinsky, K.; Oliveira, M.; Traina, T. A.; Tolaney, S. M.; Loirat, D.; Punie, K.; Hurvitz, S. A.; Lynce, F.; Hamilton, E. P.; Nanda, R.; Hart, L. L.; Richards, P. D.; Malik, Z. A.; Rugo, H. S.; Dieras, V.; Bardia, A.; Hong, Q.; Olivo, M. S.; Itri, L.; Loibl, S. |
| Abstract Title: | Outcomes in patients (pts) aged ≥ 65 years in the phase 3 ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120600116 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.1011 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1011 -- Source: Wos |
